Bill Aims to Reduce Teen Abuse of Cough Syrup
Two senators introduced a bill this week designed to prevent the abuse of cough syrup by teenagers. The bill restricts the sale of products containing the cough syrup ingredient dextromethorphan (DXM) to those older than 18, Drug Store News reports.
Senator Bob Casey of Pennsylvania and Senator Lisa Murkowski of Alaska sponsored the measure, known as the Preventing Abuse of Cough Treatments (PACT) Act of 2012. The PACT Act also places limits on the purchase of bulk (unfinished) DXM, so that only manufacturers registered with the Food and Drug Administration or relevant state agencies have access to DXM in its raw form. Currently, there are no national restrictions on sales or purchase of DXM in this form.
The 2011 Monitoring the Future survey found that 5 percent of teens report abusing cough medicine. Abuse of DXM can cause hallucinations, confusion, blurred vision and loss of motor control.
Photos courtesy of and copyright stock.xchng, http://www.sxc.hu/